Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,895 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
STAT1 as a potential therapeutic target to treat bladder cancer (2024-09-15)
Journal: International Journal of Clinical and Experimental Pathology (2024) IF: 1.1DOI: 10.62347/HYCN1717Products Cited: -
Activation of cGAS confers PARP inhibitor resistance in ovarian cancer via the TBK1-IRF3 axis (2024-11-15)
Journal: International Journal of Clinical and Experimental Pathology (2024) IF: 1.1DOI: 10.62347/XOPN6908Products Cited: -
Schisandrin A Alleviates Inflammation and Oxidative Stress in Aβ25-35-Induced Alzheimer’s Disease in Vitro Model (2024-10-05)
-
Single-cell RNA sequencing and bulk sequencing reveal the immunosuppressive role of malignant cells in triple-negative breast cancer (2024-06-13)
Journal: Gene Reports (2024) IF: 1 -
miR-16-5p may modulate migration and proliferation through TP53 and LncRNA-NEAT1 in triple-negative breast cancer (2024-09-20)
Journal: Gene Reports (2024) IF: 1Products Cited: MCF 10A Cell Complete Medium -
FOXM1 derived from Triple negative breast cancer exosomes promotes cancer progression by activating IDO1 transcription in macrophages to suppress ferroptosis and induce M2 polarization of Tumor-associated macrophages (2024-10-18)
-
Melittin Alleviates Oxidative Stress Injury in Schwann Cells by Targeting Interleukin-1 Receptor Type 1 to Downregulate Nuclear Factor Kappa B-Mediated Inflammatory Response In Vitro (2024-07-30)
Journal: Cureus Journal of Medical Science (2024) IF: 1DOI: 10.7759/cureus.65721Products Cited: Rat Schwann Cells -
Synthesis and Preclinical Evaluation of [18F]AlF-NOTA-Asp2-PEG2-Folate as a Novel Folate-Receptor-Targeted Tracer for PET Imaging (2024-07-23)
Journal: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2024) IF: 0.9DOI: 10.1002/jlcr.4118Products Cited: RPMI-1640 (Dutch Modification), without folic acid, HEPES Medium -
Preliminary Research of Radiolabeled Atezolizumab for the Noninvasive Evaluation of TNBC PD-L1 Expression In?Vivo (2024-08-30)
Journal: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2024) IF: 0.9DOI: 10.1002/jlcr.4122Products Cited: -
STRAP Knockdown Inhibits Migration and Growth of Non-Small Cell Lung Cancer (2024-10-26)
Journal: BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2024) IF: 0.9Products Cited: BEAS-2B Cells Line
